Case Study
Accelerating
Therapeutic Development
Explore how advanced proteomic profiling reveals Semaglutide’s broader therapeutic potential and accelerates clinical research.
Explore how advanced proteomic profiling reveals Semaglutide’s broader therapeutic potential and accelerates clinical research.
This case study shows how the SomaScan™ Assay delivers novel mechanistic insights, speeds drug development, and uncovers new opportunities for repurposing.